Literature DB >> 21946824

Myocardial oxidative stress protection by sevoflurane vs. propofol: a randomised controlled study in patients undergoing off-pump coronary artery bypass graft surgery.

Mayte Ballester1, Julio Llorens, Jose Garcia-de-la-Asuncion, Jaime Perez-Griera, Eduardo Tebar, Juan Martinez-Leon, Javier Belda, Marina Juez.   

Abstract

CONTEXT: Myocardial oxidative stress plays an essential role in the pathogenesis of ischaemia-reperfusion injury associated with coronary artery bypass grafting (CABG). Both propofol and volatile anaesthetics have been shown to reduce reactive oxygen species in experimental and clinical studies. MAIN
OBJECTIVE: To compare the influence of sevoflurane and propofol on myocardial oxidative stress markers (F2-isoprostanes and nitrates/nitrites) in coronary sinus blood samples from patients undergoing off-pump CABG. DESIGN AND
SETTING: Randomised controlled clinical study of patients scheduled for off-pump CABG in a tertiary academic university hospital from June 2007 to August 2009. Forty patients consented to enrolment and were assigned to receive either propofol or sevoflurane.
INTERVENTIONS: Upon completion of the proximal anastomosis, a retroplegia cannula was inserted in the coronary sinus to obtain blood samples, according to the study protocol. MAIN OUTCOME MEASURES: Markers of lipoperoxidation (F2-isoprostanes) and nitrosative stress (nitrates/nitrites) were measured in coronary sinus blood samples at three time points: after the end of the proximal anastomosis (T1), after completion of all grafts (T2) and 15 min after revascularisation (T3).
RESULTS: Of the 40 recruited patients, 38 fully completed the study. In the sevoflurane group (n = 20), concentrations of oxidative stress markers in the coronary sinus remained almost constant and were significantly lower than those in the propofol group (n = 18) at all time points. F2-isoprostanes concentrations were as follows at T1: sevoflurane group 37.2 ± 27.5 pg ml vs. propofol group 170.7 ± 30.9 pg ml [95% confidence interval (CI) 112.16-155.08, P < 0.0001); at T2: sevoflurane group 31.94 ± 24.6 pg ml vs. propofol group 171.6 ± 29.7 pg ml (95% CI 119.78-159.63, P < 0.0001); and at T3: sevoflurane group 23.8 ± 13.0 pg ml vs. propofol group 43.6 ± 31 pg ml (95% CI 2.87-36.63, P = 0.023).
CONCLUSION: In patients undergoing off-pump CABG, sevoflurane showed better antioxidative properties than propofol.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946824     DOI: 10.1097/EJA.0b013e32834bea2a

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  15 in total

1.  Oxidative stress injury after on-pump cardiac surgery: effects of aortic cross clamp time and type of surgery.

Authors:  José García-de-la-Asunción; Ernesto Pastor; Jaime Perez-Griera; Francisco Javier Belda; Tania Moreno; Eva García-del-Olmo; Francisco Martí
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

Review 2.  Anesthesia Protocols used to Create Ischemia Reperfusion Myocardial Infarcts in Swine.

Authors:  Ana Abad Cobo; Francisco M Sánchez Margallo; Claudia Báez Díaz; Virginia Blanco Blázquez; Irene González Bueno; Verónica Crisóstomo
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-07-24       Impact factor: 1.232

Review 3.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

Review 4.  Anaesthetics as cardioprotectants: translatability and mechanism.

Authors:  C Kikuchi; S Dosenovic; M Bienengraeber
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

5.  Sevoflurane-Remifentanil Versus Propofol-Remifentanil Anesthesia During Noncardiac Surgery for Patients with Coronary Artery Disease - A Prospective Study Between 2016 and 2017 at a Single Center.

Authors:  Zhongliang Dai; Miao Lin; Yali Li; Wenli Gao; Ping Wang; Juan Lin; Zhenzhen Wan; Yuanxu Jiang
Journal:  Med Sci Monit       Date:  2021-08-21

Review 6.  Myocardial conditioning techniques in off-pump coronary artery bypass grafting.

Authors:  Marco Moscarelli; Prakash P Punjabi; Gamov I Miroslav; Paolo Del Sarto; Francesca Fiorentino; Gianni D Angelini
Journal:  J Cardiothorac Surg       Date:  2015-01-20       Impact factor: 1.637

7.  Meta-analysis of the cardioprotective effect of sevoflurane versus propofol during cardiac surgery.

Authors:  Feng Li; Yuan Yuan
Journal:  BMC Anesthesiol       Date:  2015-09-24       Impact factor: 2.217

8.  Additive Effect on Survival of Anaesthetic Cardiac Protection and Remote Ischemic Preconditioning in Cardiac Surgery: A Bayesian Network Meta-Analysis of Randomized Trials.

Authors:  Alberto Zangrillo; Mario Musu; Teresa Greco; Ambra Licia Di Prima; Andrea Matteazzi; Valentina Testa; Pasquale Nardelli; Daniela Febres; Fabrizio Monaco; Maria Grazia Calabrò; Jun Ma; Gabriele Finco; Giovanni Landoni
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

Review 9.  Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia.

Authors:  G Kunst; A A Klein
Journal:  Anaesthesia       Date:  2015-04       Impact factor: 6.955

10.  Silencing of PTEN inhibits the oxidative stress damage and hippocampal cell apoptosis induced by Sevoflurane through activating MEK1/ERK signaling pathway in infant rats.

Authors:  Tiejun Liu; Xiaoliu Dong; Bin Wang; Shubo Zhang; Jing Bai; Wei Ma; Xiaojing Zhao; Xiaotao Wang
Journal:  Cell Cycle       Date:  2020-02-23       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.